NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The NIST reference material, called NISTCHO, will help the biopharmaceutical industry develop new drugs more quickly and ensure that they are safe and effective
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL) announces the selection of 100 first- and second-year college students to
Today, Commissioners from the National Security Commission on Emerging Biotechnology (NSCEB), along with Senator Chris Coons (D-DE) and Representative Sarah
Gaithersburg, MD - March 1, 2024 – The NIST Office of Advanced Manufacturing , which serves as the coordinating office for Manufacturing USA , a national
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to
Join us for the 2023 NIIMBL eXperience The NIIMBL eXperience is an exclusive in-person, all expenses paid immersion program that offers you real-world insight
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded over $200k in funding to launch the 2023 NIIMBL eXperience
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in collaboration with BioPhorum is pleased to announce that the data and
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) launches NIIMBL bioLOGIC, a pilot program designed to bring awareness to and
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a
Manufacturing is the backbone of America, powering our economy and building our middle class. Over the past year and a half, we have been making “Buy American”
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to lay the
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities
PowerAmerica has been awarded a $5 million cooperative agreement from the National Institute of Standards and Technology (NIST) to help Native American
GAITHERSBURG, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded nearly $54 million in grants for 13 high
Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations
Zack Valdez’s story is one of family, self-discovery, research and advocacy. Growing up in Dallas, Zack’s childhood was shaped by his multicultural family of
ROCKVILLE, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST), the National Institute for Innovation in Manufacturing
WASHINGTON — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National
GAITHERSBURG, Md. — Today, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) announced a new competition for awards to
GAITHERSBURG, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has opened a funding opportunity for rapid, high